On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Diabetes Treatment and Management

TopicLeading institutions, researchers & key papers

Diabetes Treatment and Management is a topic indexed in ScholarIQ from OpenAlex.

What is known about Diabetes Treatment and Management?

ScholarIQrecord summary

This cluster of papers focuses on the management of diabetes mellitus, with a particular emphasis on cardiovascular outcomes, glucose control, and the use of incretin hormones, SGLT2 inhibitors, and dipeptidyl peptidase-4 inhibitors. It also covers topics such as heart failure, glycemic control, insulin therapy, and clinical guidelines for the treatment of type 2 diabetes.

How many works does Diabetes Treatment and Management have?

ScholarIQindexed works

Diabetes Treatment and Management has 1,233 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Diabetes Treatment and Management?

ScholarIQopenalex

The OpenAlex for Diabetes Treatment and Management is on the source record.

What are the most-cited papers on Diabetes Treatment and Management?

ScholarIQmost cited works
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Silvio E. Inzucchi
New England Journal of Medicine. 201512,121 CitationsOPEN ACCESS
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R. Matthews
New England Journal of Medicine. 20177,831 CitationsOPEN ACCESS
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel, David R. Matthews, H. A. W. Neil
New England Journal of Medicine. 20087,788 CitationsOPEN ACCESS
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen, Peter Lommer Kristensen, Johannes F.E. Mann, Michael A. Nauck, Steven E. Nissen, Stuart Pocock, Neil R Poulter, Lasse Steen Ravn, William M. Steinberg, Mette Stockner, Bernard Zinman, Richard M. Bergenstal, John B. Buse
New England Journal of Medicine. 20167,491 CitationsOPEN ACCESS
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
The ADVANCE Collaborative Group
New England Journal of Medicine. 20087,445 CitationsOPEN ACCESS

Where is Diabetes Treatment and Management research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Diabetes Treatment and Management is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
7%
Hybrid
0%
Bronze
93%
Closed
0%

Related on ScholarIQ

470M+ articles · 14-day free trial